Daisuke Minakata

MRD-guided induction-intensification with daratumumab–carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma

Daizo Yokoyama, Daisuke Minakata, Shin-ichiro Fujiwara, Seina Honda et autres

jp (code pays fourni par la source)

Response-adapted lenalidomide–dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study

Daisuke Minakata, Go Yamamoto, Shinichi Kako, Yuki Hiroshima et autres

jp (code pays fourni par la source)

Haploidentical hematopoietic stem cell transplantation using low-dose alemtuzumab is effective for standard-risk hematological malignancies

Shinichi Kako, Shin-ichiro Fujiwara, Yuhei Nakamura, Masakatsu Kawamura et autres

jp (code pays fourni par la source)

Significance of the tendency for relative bradycardia during induction therapy for acute myeloid leukemia

Ryutaro Tominaga, Shin‐ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi et autres

jp (code pays fourni par la source)

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan

Masaya Megaki, Tsutomu Takahashi, Kazuhito Suzuki, Daisuke Minakata et autres

jp (code pays fourni par la source)

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma

Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin‐ichiro Fujiwara et autres

jp (code pays fourni par la source)

Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Koji Kawamura, Nobuhiro Tsukada, Shun‐ichi Kimura, Shinichi Kako et autres

jp (code pays fourni par la source)

Author response for "Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma"

Koji Kawamura, Nobuhiro Tsukada, Shun‐ichi Kimura, Shinichi Kako et autres

Author response for "Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma"

Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin Fujiwara et autres

Author response for "Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma"

Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin Fujiwara et autres

Risk factors for influenza virus infection in patients with hematological disease

Hirotomo Nakashima, Shin-ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama et autres

jp (code pays fourni par la source)

Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma

Daisuke Minakata, Shin‐ichiro Fujiwara, Ryutaro Tominaga, Daizo Yokoyama et autres

jp (code pays fourni par la source)